Aurovir Pharma Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Angel

  • Investors
  • 1

Aurovir Pharma General Information

Description

Developer of gold-ion-based inhaled therapies designed for the treatment of pulmonary disorders. The company utilizes aurothioglucose and a proprietary formulation process to deliver gold ions directly to the lungs, enabling healthcare providers to treat viral infections, inflammatory diseases, and lung cancer through targeted protein interaction and extended on-target half-life.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Corporate Office
  • Riglergasse 4
  • Vienna, Vienna 1180
  • Austria
+43 0676
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • Riglergasse 4
  • Vienna, Vienna 1180
  • Austria
+43 0676

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aurovir Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Angel (individual) 01-Jun-2025 Completed Generating Revenue
To view Aurovir Pharma’s complete valuation and funding history, request access »

Aurovir Pharma Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Startup Angels Alb-Bodensee Angel Group Minority
To view Aurovir Pharma’s complete investors history, request access »

Aurovir Pharma FAQs

  • When was Aurovir Pharma founded?

    Aurovir Pharma was founded in 2023.

  • Where is Aurovir Pharma headquartered?

    Aurovir Pharma is headquartered in Vienna, Austria.

  • What industry is Aurovir Pharma in?

    Aurovir Pharma’s primary industry is Drug Discovery.

  • Is Aurovir Pharma a private or public company?

    Aurovir Pharma is a Private company.

  • What is Aurovir Pharma’s current revenue?

    The current revenue for Aurovir Pharma is .

  • Who are Aurovir Pharma’s investors?

    Startup Angels Alb-Bodensee has invested in Aurovir Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process